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ABSTRACT 
Objective: Bacteria have developed ability to resist antibiotics that previously served as effective treatment. There is an increasing concern by 
health care providers to address this problem in healthcare settings especially in underdeveloped countries where access to the latest antibiotics is 
limited. These antibiotic resistant pathogens, both Gram-positive and Gram-negative bacteria, usually found in health care facilities, can cause 
severe to fatal infections. Our research focused on five of the most problematic bacteria: Methicillin-resistant Staphylococcus aureus (MRSA), 
Methicillin-sensitive Staphylococcus aureus (MSSA), Acinetobacter baumannii, Klebsiella pneumoniae, and Pseudomonas aeruginosa.  
Methods: For centuries home treatments have relied on the use of essential oils to treat ailments. We tested four commonly found essential oils 
(wintergreen, cinnamon, tea tree, and spearmint) against the five bacteria as well as methylglyoxal, which is an ingredient in Manuka honey. The 
Kirby-Bauer disk diffusion method was used and diameter of the zone of inhibition for each bacterium was measured to compare with standard 
antibiotics used for each strain of bacteria. In addition to studying the antibacterial activity of these compounds, we also investigated a way to 
deliver these compounds to patients, as topical applications, to inhibit the transmission of these multidrug resistant bacteria in healthcare settings. 
Results: Wintergreen and cinnamon essential oils as well as methylglyoxal showed high inhibitory effect on the tested bacteria. We also tested and 
found that Aloe Vera oil, Aloe Vera gel and natural Aloe Vera served as effective carriers with the essential oils and methylglyoxal.  
Conclusion: The antibacterial activity found in wintergreen and cinnamon essential oils and in methylglyoxal may offer a cost-effective alternative 
to commercial antibiotics because these compounds are readily available and relatively inexpensive and would be a benefit to people globally. 
Keywords: Methicillin Resistant Staphylococcus aureus (MRSA), Methicillin Sensitive Staphylococcus aureus (MSSA), Acinetobacter baumanni, 
Klebsiellapneumoniae, Pseudomonas aeruginosa, Manuka, Methylglyoxal, Wintergreen, Cinnamon, Aloe Vera, Antibiotic resistance. 
 
INTRODUCTION 
Before the discovery of microorganisms, mankind was successful in 
using certain plants that were known to have healing potential [1]. 
Various plants and honeys were known to be an effective treatment 
against fighting infections and were commonly used in treating 
wounds. In particular, various types of honey show broad-spectrum 
antimicrobial activity and show effectiveness against antibiotic 
resistant bacterial pathogens [2-4]. The capability of essential oils to 
act as antiseptics is thought to come from the need of plants to be 
able to withstand harsh elements of nature, including a large degree 
of deadly microorganisms [5]. Various studies have tested and 
confirmed that a large number of essential oils have proven to be 
effective antimicrobial agents [6-8]. Various species of plants have 
been used for centuries to aid in fighting bacterial infections and 
many still continue to play a vital role in medicine. Today, the use of 
commercial antibiotic stands to serve as the main source of 
treatment of infectious diseases. 
In modern times the anti-infectious procedure developed by humans 
including hygienic measures, epidemiological controls, vaccines, and 
antibiotics [9], have limited the evolution of pathogenic organisms. 
Many strains of bacteria, however, have developed mechanisms 
through which they become resistant to antibiotics and 
consequently lead to difficulty in treating infected patients [10]. 
Antibiotic resistance by certain pathogens remains to be a growing 
problem in the world and has been adversely affecting the lives of 
hundreds and thousands of people every year. The Staphylococcus 
aureus is a Gram-positive bacterium. Staph aureus can be defined 
into two strains according to their sensitivity to oxacillin, a beta 
lactam marker. Oxacillin susceptibility is a measure of 
Staphylococcus activity towards beta lactam antibiotics. Beta lactam 
works by impairing the cell’s ability to synthesize the peptidoglycan 
layer, by binding to the penicillin binding protein (enzymes) that is 
essential for peptidoglycan synthesis. Strains of Staphylococcus 
aureus that are sensitive to these antibiotics are known as 
Methicillin Sensitive Staphylococcus aureus (MSSA). Strains of 
Staphylococcus aureus that are resistant to oxicillin are known as 
Methicillin Resistant Staphylococcus aureus (MRSA). MRSA has 
become a 'superbug' that has emerged in both community and 
hospital environments resulting in many patients developing 
infections. Vancomycin is the current standard treatment used 
against MRSA; however, treatment failures have been documented 
more frequently in the recent past [23]. The judicious use of 
antibiotics is essential if multi-resistant strains of MRSA are not to 
become more prevalent [11]. The ways that Staphylococcus aureus 
infections are defined include hospital-acquired MRSA (HA-MRSA) 
and community acquired MRSA (CA-MRSA). The Centers for Disease 
Control and Prevention (CDC) has estimated that there are 1.7 
million healthcare-associated infections (HAIs) annually in the 
United States, which results in 99,000 deaths and $4.5 billion in 
excess healthcare costs [12]. A persistent problem that the world 
currently faces is the escalation of resistance mechanisms in 
bacteria, which accounts for substantial increase in related illnesses 
and deaths every year. Antibacterial agents such as those tested in 
this study may reduce these infections and prove to be cost-effective 
by reducing the duration of hospital stay. 
In addition to MRSA and MSSA, there are Gram-negative multidrug 
resistant bacteria found in the hospital settings. Three of the more 
problematic Gram-negative bacteria are Acinetobacter baumannii, 
Klebsiella pneumoniae, and Pseudomonas aeruginosa [13]. Of these, P. 
aeruginosa ranks second among the Gram-negative pathogens in 
causing nosocomial infections, with a 58.8% mortality rate [14]. K. 
pneumoniae is a common cause of pneumonia and bacteremia in 
critically ill patients. An increasing number of strains of K. 
pneumoniae are growing resistant to virtually all antibiotics, with a 
mortality rate of 50% [15], therefore making it crucial to control its 
spread. Acinetobacter baumannii is also one of the most problematic 
causative agents of nosocomial infections because of its ability to 
survive on hospital surfaces and acquire antibiotic resistance, 
resulting in the global emergence of strains with resistance to 
multiple antibiotic classes [16].  
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Infections caused by MRSA, MSSA, A. baumannii, K. pneumoniae, and 
P. aeruginosa can cause life-threatening complications. Patient’s 
cellulitis, post surgical site infections or respiratory pneumonia, may 
result in bloodstream infections, which can complicate and lead to 
death. For example, in 2005 it was recorded that approximately 
94,000 people developed their first invasive MRSA infection, of 
which about 19,000 died in the United States [17]. 
The five bacteria tested in this study are commonly found in 
hospitals and play a major role in the health of patients that are 
admitted due to various other types of diseases. In order to reduce 
the chances of patients acquiring these infections, it is important to 
find alternatives that are successful in inhibiting the growth of these 
bacteria and reduce the number of deaths. With each small battle 
that humans have fought against bacteria with finding new 
antibiotics and treatments, bacterial infections are still not fully 
under control because of the escalation of drug resistance 
mechanisms. The present research studied antibacterial activity of 
wintergreen and cinnamon essential oils and methylglyoxal. We also 
tested these compounds as topical applicants with carriers such as 
Aloe Vera gel, Aloe Vera oil, natural Aloe Vera and lanolin for easy 
application on soft tissue infected patients.  
The published work reveals that Manuka honey obtained from the 
Manuka tree (Leptospermum scoparium) in New Zealand provided 
greater antibacterial activity than any other honey [18]. Manuka 
honey has been reported to be a promising functional food, which 
can also be used for the treatment of wounds and/or stomach ulcers 
because of its ability to exhibit antimicrobial activity against 
pathogenic bacteria such as Staphylococcus aureus[19]. 
Antimicrobial activity in most honeys is due to the enzymatic 
production of hydrogen peroxide [20]. However, methylglyoxal has 
been shown to be the active ingredient in Manuka honey and 
Manuka oil [21]. The methylglyoxal also provides suitable properties 
such as being resistant to heat, body fluids, light and enzymatic 
activity [22]. The use of such a compound may prove to be highly 
suitable for patients in hospitals, for the prevention and cure of 
these harmful infections.  Finding an alternative treatment is crucial. 
Commonly used antibiotics to treat patients with A. baumannii, K. 
pneumoniae and P. aeruginosa infections are ampicillin/sulbactam, 
piperacillin/ tazobactam and or amikacin respectively. And 
recommended antibiotics to treat MSSA and MRSA are nafcillin and 
vancomycin respectively. Using specific essential oils and 
methylglyoxal for treating MRSA, MSSA, A. baumannii, K. 
pneumoniae, and P. aeruginosa may prove to be more effective than 
the common antibiotics. 
MATERIALS AND METHODS 
Essential oils 
The following essential oils were obtained from West Village Oil 
Company of Glendale, NY, USA: Wintergreen, cinnamon, tea tree, and 
spearmint in order to be used in this research. According to the 
supplier, all of the essential oils were obtained through steam 
distillation. Manuka honey was obtained from ApiHealth New 
Zealand Limited (LTD) and the Manuka essential oil was obtained 
from Barrier Gold- GBI, New Zealand in order to be used for this 
research. Methylglyoxal (40% in H2
1. Vancomycin used for MRSA was used in 5 μg disc form (BD- 
231352). 
O) was purchased from Sigma-
Aldrich®, Missouri, USA.  
The standard antibiotics  
The antibiotics used as standards for this research were obtained 
from the Becton, Dickinson and Company (BD), NJ, USA. 
2. Streptomycin used for MSSA was used in 10 μg disc form (BD- 
231328). 
3. Amikacin used for P. aeruginosa was used in 30 μg disc form (BD- 
231597). 
4. Piperacillin/ Tazobactam used for K. pneumoniae was used in 100 
μg or 10 μg disc forms, respectively (BD- 2094208). 
5. Ampicillin used for A. baumannii was used in 10 μg disc form (BD- 
231660). 
Bacterial drug resistant organisms used to test antibacterial 
activity 
Methicillin Resistant Staphylococcus aureus (MRSA) and Methicillin 
Sensitive Staphylococcus aureus (MSSA) samples were obtained from 
Jersey Shore University Medical Center (JSUMC) anonymous positive 
blood culture isolates placed on blood agar plates. A. baumannii 
(ATCC-19606), K. pneumoniae (ATCC-13883), and P. aeruginosa 
(ATCC-27853) samples were obtained from American Type Culture 
Collection (ATCC®, Virginia, USA) and grown under aerobic 
condition on Mueller Hinton II medium for 24 hours under an 
incubation period.  
Supply of emollients 
Among the emollients used, Aloe Vera oil was obtained from House 
of Nubian, Jersey City, NJ, Aloe Vera 100% Gel was obtained from 
Fruit of the Earth, Fort Worth, TX, USA and natural Aloe Vera was 
the product of Squidbat, AZ, USA. 
Preparation of muellar-hinton II agar medium 
BD Difco™ Mueller Hinton II agar medium was used to provide the 
important nutrients to support the growth of MRSA and MSSA. This 
medium proved to be a suitable medium to perform susceptibility 
testing as well as for growing the microorganisms. It was prepared 
from a commercially available dehydrated powder as per the 
manufacturer’s instructions. Once prepared, the agar was autoclaved 
and then poured into sterilized Petri dishes.  
Disk diffusion (Kirby Bauer) method 
The bacteria were cultured separately in nutrient broths and the 
disk diffusion test was performed to see the zones of inhibition by 
the compounds tested. The bacterial cultures were matched to a 0.5 
McFarland standard 1 x 108
Wintergreen and cinnamon essential oils as well as methylglyoxal 
obtained from Manuka honey were tested for antibacterial activity 
against multidrug resistant bacteria: MRSA, MSSA, A. baumannii, K. 
pneumoniae, and P. aeruginosa, and found to be more effective than 
the respective standard antibiotics for each of the five tested 
bacteria (Table 1 and fig. 1). Spearmint and tea tree essential oils 
were also tested in this study, however, the results obtained were 
not better than the respective standard antibiotics (Table 1 and 2). 
Wintergreen, cinnamon and methylglyoxal were highly effective in 
inhibiting the growth of MRSA, MSSA and A. baumannii. Wintergreen 
essential oil was also effective in inhibiting the growth of K. 
pneumoniae, better than the standard antibiotic, 
piperacillin/tazobactam. This was not the case with cinnamon 
essential oil and methylglyoxal. Similarly, these three compounds 
did not show better results with P. aeruginosa than the standard 
antibiotic, amikacin (Table 1). However, the zones of inhibition 
created by these compounds with P. aeruginosa were still significant. 
 Colony Forming Units per milliliter 
(CFU/ml) test tube. The Mueller Hinton II agar was poured into petri 
dishes and then allowed to solidify. After solidification, the bacterial 
cultures were grown on the Mueller Hinton II and then tested with 
specific compounds such as Manuka honey, Manuka oil, methyl 
glyoxal and essential oils. The plates were then incubated for 
approximately 24 hours. The zones of inhibition by the compounds 
were with the zone of inhibition by the standard antibiotics- 
vancomycin, streptomycin, ampicillin/sulbactam, pipercillin/ 
tazobactam, and amikacin. 
The experiments were carried out in triplicate and were performed 
under aseptic conditions. Sterile blank discs (6 mm) were saturated 
with 5 μL of one of the compounds being tested. Each of the 
antibiotic standards was placed on a similar blank disc and 
positioned in the middle of the petri dish. The zones of inhibition by 
the different antibiotics for the different strains of bacteria were 
tested in this manner. The diameters of zones of inhibition were 
measured after 24 hours of incubation at 37°C.  
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Table 1: Mean diameter of zone of inhibition of standard antibiotics used to treat multidrug resistant bacteria 
Bacteria Standard antibiotic Mean diameter of zone of inhibition (mm) 
MRSA Vancomycin 15 
MSSA Streptomycin 15 
A. baumannii Ampicillin/ Sulbactam 29 
K. pneumoniae Piperacillin/ Tazobactam 31 
P. aeruginosa Amikacin 24 
 
Table 2: mean diameters of zone of inhibition of methylglyoxal, and wintergreen, cinnamon, tea tree and spearmint essential oils at 
various dilutions 










Methylglyoxal 40% (aq.) 29.6 33.6 21.4 42.0 41.2 
Methylglyoxal 20% (aq.) 24 28 18 35 37 
Methylglyoxal 10% (aq.) 20 21 14 32 32.5 
Wintergreen  36 35 9.3 28.5 34.5 
Wintergreen 50% (aq.) 45 41 0 23 37 
Cinnamon 27.8 36.2 20.8 33.7 37.7 
Cinnamon 50% (aq.) 30 31 20 33 37 
Cinnamon 25% (aq.) 30 29 18 35 39 
Tea Tree 13.8 12.8 0 0 0 
Spearmint 14.5 12 0 0 9.5 
 
 
Fig. 1: Efficacy of Methylglyoxal, and Wintergreen, Cinnamon, 
Tea Tree and Spearmint Essential Oils on Common Multi-Drug 
Resistant Bacteria 
 
This study appears to be the first to test methylglyoxal, wintergreen 
and cinnamon essential oils on hospital derived patient samples of 
MRSA and MSSA, as well as on three Gram-negative multidrug 
resistant organisms: K. pneumoniae, A. baumannii and P. aeruginosa.  
Dilute aqueous solutions of wintergreen, cinnamon essential oil as 
well as methylglyoxal, prepared by using sterilized water, were also 
tested against the five drug resistant bacteria. Methylglyoxal (40%) 
was diluted to 20% and 10% aqueous solutions, whereas 
wintergreen was diluted to 50%, and cinnamon essential oil was 
diluted to 50% and 25% aqueous solutions (Table 2). The results of 
the tests showed that these compounds, even as diluted aqueous 
solutions are more effective in inhibiting the growth of MRSA, MSSA 
and A. baumannii, and almost as effective with K. pneumoniae and P. 
aeruginosa compared to the respective standard antibiotics. This 
study demonstrates that wintergreen and cinnamon essential oils 
and methylglyoxal could be beneficial in treating infections caused 
by these bacteria.  
Natural Aloe Vera, Aloe Vera oil, and commercial Aloe Vera gel were 
used as carriers for the essential oils and methylglyoxal. The gel 
from the natural Aloe Vera leaf was aseptically removed and used 
with the essential oils and methylglyoxal in equal quantities. The 
results of this procedure (fig. 2) indicated that natural Aloe Vera gel 
when combined with methylglyoxal and wintergreen decreased the 
zones of inhibition with the five bacterial species tested. However, 
when natural Aloe Vera gel was combined only with cinnamon 
essential oil, the activity was enhanced. The mean of zones of 
inhibition obtained for MRSA, K. pneumoniae and P. aeruginosa with 
the cinnamon essential oil alone were 33.7 mm, 27.8 mm and 20.8 
mm, respectively (fig. 1). These zones of inhibition increased with 
the use of natural Aloe Vera gel to 35.0 mm, 40.0 mm and 31.0 mm, 
respectively (fig. 2). The mean zones of inhibition obtained for MSSA 
and A. baumannii with the cinnamon essential oil alone were 37.7 
mm and 36.0 mm, respectively (fig. 1). These zones of inhibition 
decreased with the use of natural Aloe Vera gel to 36.0 mm and 18.0 
mm, respectively (fig. 2).  
 
 
Fig. 2: Carrier Natural Aloe Vera with Methylglyoxal, 
Wintergreen and Cinnamon 
 
Aloe Vera oil was also tested as another carrier for the essential oils 
and methylglyoxal on the five different bacterial species. The Aloe 
Vera oil was used in equal quantities with the wintergreen and 
cinnamon essential oils, as well as methylglyoxal. The results 
showed that the activity of the Aloe Vera oil in conjunction with 
methylglyoxal, wintergreen and cinnamon essential oils showed 
high mean zones of inhibition for P. aeruginosa. The mean zones of 
inhibition obtained for P. aeruginosa with the methylglyoxal, 
wintergreen and cinnamon essential oils (without a carrier) were 
21.4 mm, 9.30 mm, and 20.8 mm, respectively (fig. 1). These zones of 
inhibition increased with the use of Aloe Vera oil to 33.0 mm, 28.0 
mm and 27.0 mm, respectively (fig. 3). Similarly, an increase in the 
mean zones of inhibition was evident for MRSA and MSSA when 
used with cinnamon essential oil and Aloe Vera oil, and a 
combination of methylglyoxal and Aloe Vera oil showed an increase 
when tested with K. pneumoniae. 
Commercial Aloe Vera gel was also tested as another source of 
emollient and the results showed that when combined with the 
essential oils and methylglyoxal, the commercial gel yielded higher 
mean zones of inhibition for MRSA, MSSA, K. pneumoniae and P. 
aeruginosa. For A. baumannii, the combination showed lower zones 
of inhibition when used in conjunction with the Aloe Vera gel. The 
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results show that for MRSA treated with only wintergreen, the mean 
zone of inhibition was observed to be 28.5 mm (fig. 1), whereas the 
zone of inhibition with the Aloe Vera gel increased to 46.0 mm (fig. 
4). Similar results were observed for MSSA, K. pneumoniae and P. 
aeruginosa (fig. 4).  
Commercial Aloe Vera gel by itself was tested and showed a mean zone 
of inhibition of 19.8 mm, indicating some antibacterial activity of the 
Aloe Vera gel (fig. 4). Commercial Aloe Vera is known to contain other 
ingredients such as triethanolamine, and tocopheryl Acetate (Vitamin E) 
added in the gel. 
 
 
Fig. 3: Carrier Aloe Vera Oil with Methylglyoxal, Wintergreen 
and Cinnamon 
 
The activity of the commercial Aloe Vera gel may be due to any or a 
combination of these ingredients. The results of using emollients 
such as naturally obtained Aloe Vera, Aloe Vera oil, and commercial 
Aloe Vera gel in conjunction with methylglyoxal and wintergreen, 
and cinnamon essential oils showed that these compounds could be 
used in combination with emollients at lower concentrations as a 
form of topical treatment for treating infections caused by these 
multidrug-resistant bacteria.  
 
 
Fig. 4: Carrier Commercial Aloe Vera Gel with Methylglyoxal, 
Wintergreen and Cinnamon 
 
CONCLUSION 
In conclusion, this study revealed strong antibacterial properties of 
wintergreen and cinnamon essential oils, as well as methylglyoxal 
(active ingredient in Manuka Honey). These compounds showed 
high effectiveness against MRSA, MSSA, A. baumannii, K. pneumoniae, 
and P. aeruginosa than the respective standards antibiotics used to 
treat infections caused by these bacteria. Test results (fig. 1) with 
diluted aqueous solutions of the compounds (wintergreen, 
cinnamon and methylglyoxal) showed the possibility of using these 
compounds in conjunction with emollients such as Aloe Vera. 
Results of the tests conducted with carrier oils (fig. 2, 3, 4) 
demonstrated potential for using such ointments for dermatological 
use. In order to develop commercial ointments for treatment of 
bacterial infections, clinical trials using topical emollients will be 
necessary. The next phase would be to study the biochemical 
mechanism responsible for inhibiting these bacteria. Understanding 
this mechanism may lead to the development of a more effective and 
safer alternative treatment of bacterial infections. 
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